跳至主要内容
临床试验/NCT00233688
NCT00233688已完成3 期

A Prospective, Multicenter Study of the Cordis Endovascular QUANTUM LP™ Stent Graft System for the Treatment of Abdominal Aortic Aneurysms (AAA)-FORTRON

Cordis Corporation2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2001年11月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
300
试验地点
2
主要终点
To compare the aneurysm-related one-year mortality rates of the stent graft patients to open surgery patients. The purpose of having an aneurysm surgically or endovascularly repaired is to prevent death from AAA.

研究概览

简要总结

The objective of this clinical study is to assess the safety and effectiveness of the Cordis Endovascular Quantum LP™ Stent Graft System.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

To compare the aneurysm-related one-year mortality rates of the stent graft patients to open surgery patients. The purpose of having an aneurysm surgically or endovascularly repaired is to prevent death from AAA.

时间窗: One year

To compare the one-year procedure-related severe adverse event rates of the stent graft patients to open surgery patients. These events exclude aneurysm-related deaths. The endpoint for this objective will be the occurrence of any serious adverse eve

时间窗: One year

次要结局

  • To evaluate the occurrence of severe device-related adverse events as they relate to the cause of aneurysm exclusion failures (i.e., Type I and III endoleaks, significant AAA growth, or AAA rupture).(30 days, 6 mo, and annually up to five years)
  • To compare the rate and amount of blood products used in the stent graft procedure to open surgery.(At procedure)

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验